Elevated circulating high-sensitivity C-reactive protein (hs-CRP) functions as a disease-modifying factor through complement-mediated astrocytic activation rather than microglial IL-1β amplification. In this alternative mechanism, circulating hs-CRP binds to complement factor H (CFH) and disrupts complement regulation, leading to excessive C3 convertase activity and local C3a/C5a production within the central nervous system. Astrocytes, which express high levels of complement receptors C3aR and
Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
NeuroinflammationUnspecified Mechanismimmunomics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
3/11
dimensions won
Circulating hs-CRP as Disease-Modifying
9/11
dimensions won
Circulating hs-CRP as Disease-Modifying
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
0.55
Evidence
0.26
0.50
Novelty
0.40
0.60
Feasibility
0.00
0.45
Impact
0.00
0.40
Druggability
0.50
0.40
Safety
0.20
0.60
Competition
0.41
0.70
Data
0.56
0.65
Reproducible
0.10
0.55
KG Connect
0.50
0.50
Score Breakdown
Dimension
Circulating hs-CRP as Disease-
Circulating hs-CRP as Disease-
Mechanistic
0.600
0.550
Evidence
0.258
0.500
Novelty
0.400
0.600
Feasibility
0.000
0.450
Impact
0.000
0.400
Druggability
0.500
0.400
Safety
0.200
0.600
Competition
0.415
0.700
Data
0.565
0.650
Reproducible
0.100
0.550
KG Connect
0.500
0.500
Evidence
Circulating hs-CRP as Disease-Modifying Target via Astrocyti
No evidence citations yet
Circulating hs-CRP as Disease-Modifying Target via Microglia
No evidence citations yet
Debate Excerpts
Circulating hs-CRP as Disease-Modifying Target via
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration
---
## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification
**Descripti...
Skeptic
# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration
I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...
Domain Expert
# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration
## Executive Summary
The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": "Hypothesis_1",
"title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification",
"targe...
Circulating hs-CRP as Disease-Modifying Target via
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration
---
## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification
**Descripti...
Skeptic
# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration
I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...
Domain Expert
# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration
## Executive Summary
The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": "Hypothesis_1",
"title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification",
"targe...